Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
NEPHROS INC entered into License and Supply Agreement with Medica S.p.A. valued at minimum annual aggregate purchases from Medica of €4,976,000, €5,349,000, €5,750,000, €6,000,000 and (effective 2025-11-21).
- Action
- entry
- Agreement
- license
- Counterparty
- Medica S.p.A.
- Value
- minimum annual aggregate purchases from Medica of €4,976,000, €5,349,000, €5,750,000, €6,000,000 and
- Effective
- 2025-11-21
Exact text from the filing
On November 21, 2025, Nephros, Inc. (the “Company”) entered into a license and supply agreement (the “License and Supply Agreement”) with Medica S.p.A. (“Medica”), an Italy-based medical product manufacturing company, for the marketing and sale of certain filtration products based upon Medica’s proprietary Medisulfone ultrafiltration technology in conjunction with the Company’s filtration products (collectively, the “Products”), and to engage in an exclusive supply arrangement for the Products.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
NEPHROS INC terminated Prior Agreement with Medica S.p.A. (effective 2025-11-21).
- Action
- termination
- Agreement
- license
- Counterparty
- Medica S.p.A.
- Effective
- 2025-11-21
Exact text from the filing
The License and Supply Agreement supersedes and replaces that certain License and Supply Agreement, dated December 11, 2023 (the “Prior Agreement”), between the Company and Medica, which Prior Agreement was terminated by the parties upon entry into the License and Supply Agreement.
View on SEC.gov